• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Activation-Induced Cytidine Deaminase (AID) Links epidermal Inflammation to malignant skin tumors

Research Project

Project/Area Number 20591317
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Dermatology
Research InstitutionUniversity of Yamanashi

Principal Investigator

HARADA Kazutoshi  University of Yamanashi, 医学部附属病院, 講師 (20324197)

Project Period (FY) 2008 – 2010
Project Status Completed (Fiscal Year 2010)
Budget Amount *help
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2010: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2009: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2008: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Keywords皮膚悪性腫瘍 / 慢性炎症 / 遺伝子変異 / AID(activation induced deaminase) / 皮膚腫瘍 / 発癌 / シグナル伝達
Research Abstract

AID, a DNA mutagenic enzyme, was expressed in inflammatory skin disorders, including lichen planus, lichen sclerosis et atrophicus and DLE. The AID was not expressed in human keratinocyte cell line, however, addition of TNF-a, a inflammatory cytokine, induced the ectopic expression of AID in this cell line. These data suggested that sustained inflammation in skin yielded the ectopic expression of AID in keratinocytes. As a result of aberrant expression of AID, the enzyme induces DNA mutation and skin carcinogenesis.

Report

(4 results)
  • 2010 Annual Research Report   Final Research Report ( PDF )
  • 2009 Annual Research Report
  • 2008 Annual Research Report
  • Research Products

    (7 results)

All 2010 2009 Other

All Journal Article (5 results) (of which Peer Reviewed: 5 results) Presentation (1 results) Remarks (1 results)

  • [Journal Article] Overexpression of GRIM-19 in cancer cells suppresses STAT3-mediated signal transduction and cancer growth.2010

    • Author(s)
      Okamoto T, Inozume T, Mitsui H, Kanzaki M, Harada K, Shibagaki N, Shimada S.
    • Journal Title

      Mol Cancer Ther. 9(8)

      Pages: 2333-2343

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] A case of lymphoepithelioma-like carcinoma of the skin associated with EpsteineBarr virus infection2010

    • Author(s)
      Aoki R, Mitsui H, Harada K, Kawamura T, Shibagaki N, Tsukamoto K, Murata S, Shimada S
    • Journal Title

      J AM ACAD DERMATOL 62(4)

      Pages: 681-684

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Overexpression of GRIM-19 in cancer cells suppresses STAT3-mediated signal transduction and cancer growth.2010

    • Author(s)
      Okamoto T, et al.
    • Journal Title

      Mol Cancer Ther.

      Volume: 9 Pages: 2333-2343

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Selective Role for Mek1 but not Mek2 in the Induction of Epidermal Neoplasia2009

    • Author(s)
      Scholl FA, Dumesic PA, Barragan DI, Harada K, Charron J, Khavari PA
    • Journal Title

      Cancer Res. 69(9)

      Pages: 3772-3778

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Psoriasiform eruption associated with alopecia areata during infliximab therapy.2009

    • Author(s)
      Nakagomi D, Harada K, Yagasaki A, Kawamura T, Shibagaki N, Shimada S.
    • Journal Title

      Clin Exp Dermatol. 34(8)

      Pages: 923-924

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Presentation] 遺伝子変異誘導酵素AID の皮膚悪性腫瘍発生における役割の解明2009

    • Author(s)
      原田和俊、島田眞路
    • Organizer
      第108回日本皮膚科学会総会
    • Place of Presentation
      福岡
    • Year and Date
      2009-04-25
    • Related Report
      2010 Final Research Report
  • [Remarks]

    • URL

      http://www.med.yamanashi.ac.jp/clinical/dermatol/research/researchl.html

    • Related Report
      2010 Annual Research Report

URL: 

Published: 2008-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi